Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBTNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.203NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.203NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.8.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.8.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GY.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GY.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.7.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.7.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.254NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.254NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.36.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.36.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.500NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.500NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.147NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.147NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.487NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.487NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.68NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.68NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.46NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CU.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CU.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CA.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.83NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.83NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.411NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.411NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.217NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.217NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.17 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.527NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.527NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used